Dr Eroglu on Future Steps for Assessing Ceritinib Plus Trametinib in Metastatic Melanoma
Zeynep Eroglu, MD, discusses future steps for assessing ceritinib in combination with trametinib in patients with metastatic melanoma.
Stay updated with breaking news from Oncologic Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zeynep Eroglu, MD, discusses future steps for assessing ceritinib in combination with trametinib in patients with metastatic melanoma.
SOUTH JORDAN - Merit Medical Systems, Inc. , a global leader of healthcare technology, has received US Food and Drug Administration 501 clearance for the SCOUT MD Surgical Guidance System. The...
SOUTH JORDAN, Utah, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, has ...
New guidance system marks significant advancement in breast cancer care, targeting tumor location in multiple dimensions for precise excision and successful surgeries
Rami Komrokji, MD, discusses the benefit of agents such as luspatercept-aamt in patients with very low– to intermediate-risk myelodysplastic syndromes who have not received prior treatment with erythropoiesis-stimulating agents.